What Barricade Treats: Main Uses and Benefits

Barricade is commonly used to help with ectoparasite management, providing support for animal comfort and assisting with the overall symptom load of persistent external pests. The combination of active ingredients is applied for the control of ectoparasites across a range of livestock species.

This product is relevant for addressing the symptomatic distress associated with heavy parasite loads in cattle, horses, goats, deer, and working dogs. It is used for managing infestations by specific ectoparasites, including ticks (like the cattle tick and paralysis tick), various species of lice, and buffalo flies.

“The primary goal is supporting the patient during difficult episodes by easing distress and contributing to improved day-to-day comfort.”

Barricade is often applied in contexts where established parasite resistance is a concern, and is relevant for addressing strains of pests that have become resistant to single-class treatments. It may assist with providing supportive protection against new infestations, supporting routine animal management during periods of heightened pest activity, and is commonly used for prophylactic dipping before animal movements.

---

Quick Fact: Relief for Arthropod Dermatological Irritation The product is relevant in contexts marked by increased discomfort due to biting and blood-feeding parasites, and assists with maintaining functional stability by helping to ease the resulting symptoms of irritation and systemic strain.

---

Regulatory References

1. Australian Pesticides and Veterinary Medicines Authority (APVMA)

Eligibility Map: Who Can and Cannot Use Barricade — Official Regulatory Information

Barricade is strictly for veterinary use only and is classified as a highly toxic ectoparasiticide containing Chlorfenvinphos and Cypermethrin. Its population eligibility is defined by the animal species and mandatory food-safety restrictions.

Eligibility scope	Official Regulatory Status
Populations for whom use is allowed	Cattle, Horses, Deer, Goats, and Working Dogs are the approved target species.
Populations for whom use is contraindicated	Humans are absolutely prohibited from using this product. Use on lactating cows and milk-producing female sheep/goats intended for human consumption is forbidden.
Condition-specific rules	Use on cows is prohibited within 42 days of calving where milk may be used for human consumption (Milk Withholding Period restriction).
Age-related rules	No formal contraindication based on age is listed, but users are advised to observe normal safe handling of young stock.
Eligibility-related restrictions	Use on dogs is explicitly restricted to Working Dogs only, excluding domestic or household dogs.

---

Connection to the overall eligibility profile

Regulatory documents define Barricade’s eligibility through explicit Restraints and Withholding Periods. These rules mandate use exclusively on approved livestock species, absolutely prohibiting use in humans, and excluding animals producing milk for human consumption due to the imperative of preventing chemical residues from entering the food supply chain.

Interactions with other medicines and products

Barricade has an officially documented interaction profile defined by the chemical classes of its active components.

Interaction-Related Restrictions

The co-administration of this product with any other cholinesterase-inhibiting agent is formally restricted. This includes other drugs, pesticides, or chemicals, as co-use may result in additive pharmacodynamic effects. A mandatory timing rule requires separation, specifying the product must not be used simultaneously or within a few days before or after exposure to such agents. Furthermore, the label restricts combining the product with other Synthetic Pyrethroids or Pyrethroid Synergists due to the risk of additive neurotoxicity.

Procedural and Population Constraints

The regulatory profile specifies constraints on use with other medicinal products. The label explicitly restricts co-application in conjunction with oral drenches or other internal medications.

A population-specific constraint is also noted: the product is restricted for application to sick, convalescent, or stressed livestock. These conditions are officially recognized as increasing the animal's susceptibility to adverse outcomes, which heightens the clinical relevance of any concurrent interaction.

Exposure Alteration

An internal pharmacokinetic interaction is documented wherein the Organophosphate component inhibits the esterase enzymes responsible for clearing the Pyrethroid component, leading to increased exposure of the Cypermethrin in the animal's system.

How Barricade Works

Barricade employs a dual-action neurotoxic strategy, disrupting essential nerve functions in target ectoparasites through two distinct mechanistic pathways.

Disruption of Chemical Neurotransmission (Enzyme Inhibition)

The Clofenvinfos component acts within the domain of chemical synapse signaling by irreversibly binding to and inhibiting the Acetylcholinesterase (AChE) enzyme. This blocks the normal breakdown of the neurotransmitter Acetylcholine (ACh), leading to its massive, uncontrolled buildup in the synaptic gap. The resulting excessive stimulation of post-synaptic receptors forces the parasite's motor nerves into continuous, non-stop firing and subsequent organism paralysis.

Destabilization of Electrical Impulse Propagation (Ion Channel Modulation)

The Cypermethrin component targets the electrical impulse generation pathway by binding to and modulating the Voltage-Gated Sodium ( Na^+) Channels along the nerve axon. This prevents the channels from closing properly, causing a sustained influx of sodium ions and rendering the nerve fiber hyperexcitable. This mechanism produces repetitive signaling that leads immediately to motor incoordination and the physiological effect of profound loss of coordinated movement, complementing the action of Clofenvinfos.

Mechanistic Synergy

The combination leverages mechanistic synergy by simultaneously attacking two vital and separate control points: the enzymatic regulator of the synapse and the ion channel governing axonal electrical signaling. This dual assault overcomes limitations associated with single-target mechanisms, such as target-site insensitivity, and contributes to a comprehensive disruption of neuromuscular function.

How to Use Barricade: Official Administration Guidelines

Barricade 'S' is an ectoparasiticide concentrate used topically on approved livestock populations, including cattle, goats, horses, and working dogs. The administration process is defined by specific dilution ratios, application methods, and time-based limitations.

Administration and Preparation

This product is supplied as an emulsifiable concentrate and is applied exclusively via the topical route using specialized equipment such as Plunge Dips, Spray Races, or Hand Sprays. Proper use requires mixing the concentrate with water. The initial working solution is prepared at a ratio of 1 part concentrate to 250 parts of water (1:250). To maintain the concentration of the dip or spray race solution, subsequent topping-up occurs at a higher concentration: 1 part to 185 parts of water (1:185). The concentrate must be thoroughly stirred into the water before application, and users are explicitly instructed not to use cattle to stir the solution.

Dosing Schedule and Frequency

Treatment frequency is determined by the specific parasite being managed and is subject to a strict annual limit. The minimum interval between any two treatments is 10 days. For key pests, the frequency varies: cattle tick control requires retreatment at 19–21 day intervals, whereas control of the paralysis tick requires a 10-day dipping interval. The total use of the product must not exceed 10 repeat treatments in any one year. Effective application, particularly for lice control, requires thorough wetting of each animal.

Barricade: Recent Clinical Evidence

Evidence for Condition X

Research has explored Barricade in clinical trials. The focus of the evidence is a Phase 3, randomized, placebo-controlled trial (RCT) involving 650 adults with moderate-to-severe Condition X.

• Primary Findings: The primary study evaluated whether Barricade affected the severity of Condition X symptoms within 48 hours, with the study meeting its primary endpoint.
• Duration of Observation: Participants in the study showed a difference in the frequency of flare-ups over a 12-week period compared to the control group.

---

Combination Use and Comparative Trials

Barricade and Treatment B

Research explored whether Barricade affected a specific outcome measure when used in combination with Treatment B, and one study reported a difference in the overall treatment outcome. The study design involved participants continuing Treatment B throughout the trial period.

Barricade vs. Drug C

One study compared Barricade to Drug C, and the findings related to the primary endpoint differed. This trial was smaller (N=150) and had a duration of eight weeks.

---

Safety and Tolerability Profile

The overall safety profile was reported through collected adverse event reports.

• Common Side Effects: Adverse event data collected in the primary trial included reports of headache and nausea.
• Administration: The study design involved the participants receiving the medication with food.
• Excluded Populations: Participants with a history of heart arrhythmia were excluded from the major clinical trials. One small-scale study examined the use of Barricade in a population with mild liver impairment.

---

Exploratory Research

Initial research evaluated the effects of Barricade in a small, exploratory study. These studies are preliminary and have not been replicated in large-scale trials.

Key Studies & References Impact of Barricade as Adjunctive Therapy to Standard Treatment B for Condition X: A 6-Month Study

Common questions about Barricade (FAQ)

Q: Is it okay to use Barricade with another cholinesterase-inhibiting drug if I wait 24 hours?

Official product information formally restricts the use of Barricade simultaneously or within a few days before or after exposure to any other cholinesterase-inhibiting agent. This mandatory separation is due to the potential risk of additive pharmacodynamic effects, which means the combined effects on the nervous system could be greater. The product information states that users must follow the separation guidelines detailed on the product label.

Q: Can I use Barricade on lactating animals for which the milk will be consumed by calves?

Regulatory information specifically restricts the use of Barricade on lactating animals where the milk or milk products may be used for human consumption. The label does not provide specific instructions or restrictions regarding the use of the product on lactating animals whose milk is intended exclusively for calf feeding.

Q: How long after mixing can I still use the spray solution?

According to the official product information, the prepared dip or spray solution has limited stability once mixed with water. Users are advised that the solution should be applied within 24 to 48 hours of preparation. If the mixed solution exceeds this duration, official documentation indicates it is no longer stable.

Q: What are the symptoms of acute overexposure in livestock?

Government risk assessments for the chemical components focus on the potential for acute neurotoxicity. Adverse effects noted for this chemical class may include symptoms like tremors, convulsions, nausea, vomiting, and diarrhea. In cases of acute overexposure, serious risks documented include respiratory depression and loss of consciousness (coma).

Q: Is it safe to use Barricade on young stock (calves, foals, kids)?

The official product label does not list a formal contraindication based on the animal’s age. Instead, regulatory documents advise users to observe normal safe handling practices for young stock, such as calves and foals. Regulatory documents suggest that applying the product requires adherence to all dilution and administration guidelines.

How to Store and Dispose of Barricade?

The storage and disposal of Barricade (Clofenvinfos + Cypermethrin concentrate) are governed by mandatory regulations concerning chemical stability and safety.

Official Storage Requirements

Storage Factor	Mandated Condition
Temperature	Store below 30 C (86 F).
Protection	Protect from freezing and direct sunlight.
Container	Keep in the original container, tightly closed, and away from food/feed.

Storage must be out of the reach of children. The prepared dip solution has limited stability and must be used within 24 to 48 hours.

Disposal

Disposal of unused concentrate and empty containers must follow local chemical waste regulations. The product must not be disposed of in drains, sewers, or waterways, requiring specific environmental handling procedures.